Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer (OGSG0402): Final report

被引：1
|
作者：
Kishimoto, T.
Imamura, H.
Uedou, F.
Fujitani, K.
Iijima, S.
Takiuchi, H.
Imano, M.
Shimokawa, T.
Kurokawa, Y.
Furukawa, H.
机构：
[1] Sakai Municipal Hosp, Sakai, Osaka, Japan
[2] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
[3] Natl Osaka Med Ctr, Osaka, Japan
[4] Minoh City Hosp, Mino, Japan
[5] Osaka Med Coll Hosp, Osaka, Japan
[6] Kinki Univ, Osaka, Japan
[7] Yamanashi Univ, Kofu, Yamanashi 400, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.4015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4015
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RANDOMIZED PHASE II TRIAL OF S-1 PLUS IRINOTECAN VERSUS S-1 PLUS PACLITAXEL AS FIRST-LINE TREATMENT FOR ADVANCED GASTRIC CANCER (OGSG0402)
    Fujitani, K.
    Takiuchi, H.
    Sugimoto, N.
    Imamura, H.
    Iijima, S.
    Imano, M.
    Kimura, Y.
    Kurokawa, Y.
    Tsujinaka, T.
    Furukawa, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 256 - 256
  • [2] Randomized Phase II Trial of S-1 plus Irinotecan Versus S-1 plus Paclitaxel as First-line Treatment for Advanced Gastric Cancer (OGSG0402)
    Sugimoto, Naotoshi
    Fujitani, Kazumasa
    Imamura, Hiroshi
    Uedo, Noriya
    Iijima, Shohei
    Imano, Motohiro
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    Goto, Masahiro
    ANTICANCER RESEARCH, 2014, 34 (02) : 851 - 857
  • [3] Randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin for first-line treatment of advanced gastric cancer
    Higuchi, Katsuhiko
    Koizumi, Wasaburo
    Yamada, Yasuhide
    Nishikawa, Kazuhiro
    Gotoh, Masahiro
    Fuse, Nozomu
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Negoro, Yuji
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirotumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hamada, Chikuma
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [4] A randomized phase II trial of docetaxel plus S-1 versus docetaxel plus cisplatin in advanced gastric cancer as a first-line treatment
    Jeung, H.
    Im, C.
    Rha, S.
    Ahn, J.
    Shin, S.
    Noh, S.
    Roh, J.
    Chung, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
    Dai, Yu-Hong
    Yu, Xiong-Jie
    Xu, Hui-Ting
    Zhuang, Liang
    Zhang, Ming-Sheng
    Zou, Yan-Mei
    Fu, Qiang
    Qiu, Hong
    Yuan, Xiang-Lin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [6] S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
    Koizumi, Wasaburo
    Narahara, Hiroyuki
    Hara, Takuo
    Takagane, Akinori
    Akiya, Toshikazu
    Takagi, Masakazu
    Miyashita, Kosei
    Nishizaki, Takashi
    Kobayashi, Osamu
    Takiyama, Wataru
    Toh, Yasushi
    Nagaie, Takashi
    Takagi, Seiichi
    Yamamura, Yoshitaka
    Yanaoka, Kimihiko
    Orita, Hiroyuki
    Takeuchi, Masahiro
    LANCET ONCOLOGY, 2008, 9 (03): : 215 - 221
  • [7] Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902)
    Kawase, Tomono
    Imamura, Hiroshi
    Kawabata, Ryohei
    Matsuyama, Jin
    Nishikawa, Kazuhiro
    Yanagihara, Kazuhiro
    Yamamoto, Kazuyoshi
    Hoki, Noriyuki
    Kawada, Junji
    Kawakami, Hisato
    Sakai, Daisuke
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Satoh, Taroh
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (02) : 134 - 141
  • [8] Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902)
    Tomono Kawase
    Hiroshi Imamura
    Ryohei Kawabata
    Jin Matsuyama
    Kazuhiro Nishikawa
    Kazuhiro Yanagihara
    Kazuyoshi Yamamoto
    Noriyuki Hoki
    Junji Kawada
    Hisato Kawakami
    Daisuke Sakai
    Yukinori Kurokawa
    Toshio Shimokawa
    Taroh Satoh
    International Journal of Clinical Oncology, 2024, 29 : 134 - 141
  • [9] Docetexal plus S-1 Versus Oxaliplatin plus S-1 for First-Line Treatment of Patients with Advanced Gastric Cancer: A Retrospective Study
    Wang, Mei
    Wu, Meihong
    Wang, Wei
    Wang, Qingshui
    Wang, Yajie
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (1-2) : 24 - 28
  • [10] Clinical Study of S-1 Plus Oxaliplatin Versus S-1 Plus Cisplatin as First-Line Treatment for Elderly Patients with Advanced Gastric Cancer
    Bo Deng-feng
    Hu Xiu-fu
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2015, 3 (04): : 238 - 242
12345